Atazanavir Capsule
Product Images NDC 42385-920

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Atazanavir (NDC 42385-920). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atazanavir-figue11.jpg (Atazanavir Figue11)

A data table listing drug classes and specific drugs contraindicated with atazanavir capsules. It categorizes drugs such as alpha 1-adrenoceptor antagonists, antiarrhythmics, anticonvulsants, antimycobacterials, antineoplastics, antipsychotics, and others, identifying contraindicated agents like alfuzosin, amiodarone with ritonavir, carbamazepine, rifampin, indinavir, and nevirapine. Footnotes refer to additional drug interaction information.*

FDA Label Image

Atazanavir Structure (Atazanavir Structure)

Chemical structure of Atazanavir sulfate, represented by its molecular formula diagram showing atoms and bonds, including functional groups and a sulfate component (H2SO4).*

FDA Label Image

Figure 1: Mean (sd) Steady-state Plasma Concentrations Of Atazanavir 400 mg (n=13) And 300 mg With Ritonavir (n=10) For Hiv-infected Adult Subjects With Hiv-1 Infection (Atazanavir Figure1)

A line graph showing Atazanavir plasma concentration (ng/mL) over time (hours). Two treatment groups, ATV 400 mg and ATV/RTV 300/100 mg, are plotted with error bars and sample sizes indicated. The graph includes a reference line for median wild-type EC90 at 14 ng/mL, illustrating drug concentration trends up to 24 hours post-dose.*

FDA Label Image

Atazanavir-figue12.jpg (Atazanavir Figue12)

Text listing various drug names and substances, some specifically noted for interactions when used with atazanavir and ritonavir. The list includes medications from different classes such as antiarrhythmics, anticonvulsants, statins, and herbal supplements.*

FDA Label Image

Atazanavir-figue13.jpg (Atazanavir Figue13)

Text panel listing possible symptoms or side effects including general discomfort, fever, muscle or joint aches, red or inflamed eyes like conjunctivitis, blisters, mouth sores, facial swelling, and painful, warm, or red lumps under the skin.*

FDA Label Image

Atazanavir-figue14.jpg (Atazanavir Figue14)

A partial drug facts or medication guide panel listing possible side effects or symptoms such as dark tea-colored urine, yellowing of skin or eyes, light colored stools, nausea, itching, and stomach-area pain. The document is related to a prescription drug label but does not show dosage or active ingredient information.*

FDA Label Image

Atazanavir-figue15.jpg (Atazanavir Figue15)

This image shows a text panel listing possible side effects or symptoms related to Atazanavir capsules. It includes symptoms such as pain in the right or middle upper stomach area, fever, nausea and vomiting, and yellowing of the skin or the white part of the eyes.*

FDA Label Image

Atazanavir-figue16.jpg (Atazanavir Figue16)

This panel lists various side effects including nausea, headache, stomach-area pain, vomiting, trouble sleeping, numbness or tingling in hands or feet, dizziness, muscle pain, diarrhea, depression, and fever. The text is presented as bullet points without additional medical context.*

FDA Label Image

Atazanavir-figue2.jpg (Atazanavir Figue2)

Label for Atazanavir Capsules 150 mg oral capsules, manufactured by Laurus Labs Limited. The label shows the NDC 42385-920-60 and includes storage instructions, a pharmacist note, and a warning about drug interactions. The package contains 60 capsules and is marked Rx only. Manufacturer details include Laurus Labs Inc., Berkeley Heights, NJ, and Laurus Labs Limited, India.*

FDA Label Image

Atazanavir-figue8.jpg (Atazanavir Figue8)

Atazanavir 150 mg capsule packaging label from Laurus Labs Limited. The label includes the proprietary and generic name Atazanavir Capsule, strength 150 mg highlighted in green, and a barcode. It shows Rx only designation, NDC 42385-920-06, manufacturer details, and placeholders for lot number and expiration date. Multiple identical labels are displayed in a sheet format.*

FDA Label Image

Atazanavir-figue3.jpg (Atazanavir Figue3)

Packaging label for Atazanavir Capsules 150 mg by Laurus Labs Limited, manufactured for Laurus Generics Inc. The label indicates unit-dose packaging containing 60 capsules (10 x 6) with storage instructions and a pharmacist alert. The label includes the NDC 42385-920-48 and manufacturing details for Laurus Labs Limited in India.*

FDA Label Image

Atazanavir-figue4.jpg (Atazanavir Figue4)

Label for Atazanavir Capsules, 200 mg strength, oral capsules. The label includes the NDC 42385-921-60, manufacturer Laurus Labs Limited and Laurus Generics Inc., package count of 60 capsules, and storage instructions. A warning alert advises not to cover the box with the pharmacy label and to find out medicines that should not be taken with Atazanavir Capsules.*

FDA Label Image

Atazanavir-figue9.jpg (Atazanavir Figue9)

Label for Atazanavir 200 mg oral capsules, manufactured by Laurus Labs Limited. The label includes the NDC number 42385-921-06, the product name and strength "Atazanavir Capsule 200 mg" in bold, "Rx only" designation, barcodes, and sections for lot and expiration dates. The layout repeats this information six times on the label sheet.*

FDA Label Image

Atazanavir-figue5.jpg (Atazanavir Figue5)

Atazanavir 200 mg capsules packaging label from Laurus Labs Limited. The label indicates 60 unit-dose capsules (10 x 6) with a note to pharmacists about drug interaction alerts. The packaging includes storage instructions, manufacturer details, and the NDC number 42385-921-48. The capsules are for oral use and prescription only.*

FDA Label Image

Atazanavir-figue6.jpg (Atazanavir Figue6)

Label for Atazanavir Capsules 300 mg, oral dosage form, containing 30 capsules. The label includes storage instructions, a cautionary note to pharmacists, and manufacturer information for Laurus Labs Limited and Laurus Generics Inc. It displays the NDC number 42385-922-30 and emphasizes to keep out of reach of children.*

FDA Label Image

Atazanavir-figue10.jpg (Atazanavir Figue10)

Label panel for Atazanavir Capsule 300 mg by Laurus Labs Limited showing six identical sections. Each section includes NDC 42385-922-06, a barcode, 'Rx only' status, and placeholders for lot and expiration dates. The label identifies the product as a prescription oral capsule containing 300 mg of Atazanavir.*

FDA Label Image

Atazanavir-figue7.jpg (Atazanavir Figue7)

Atazanavir 300 mg capsules packaging label from Laurus Labs Limited. The label indicates this is a unit-dose package containing 30 capsules (5 x 6). It is designated Rx only. The label includes storage instructions, a pharmacist alert about medicine interactions, and manufacturer details for Laurus Generics Inc. and Laurus Labs Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.